Last reviewed · How we verify

Adara 5% Cream US

Apotex Inc. · Phase 3 active Small molecule

Adara 5% Cream is a topical formulation containing adapalene, a third-generation retinoid that normalizes keratinization and reduces inflammation in the skin.

Adara 5% Cream is a topical formulation containing adapalene, a third-generation retinoid that normalizes keratinization and reduces inflammation in the skin. Used for Acne vulgaris (topical treatment).

At a glance

Generic nameAdara 5% Cream US
SponsorApotex Inc.
Drug classRetinoid (third-generation)
TargetRetinoic acid receptors (RARs)
ModalitySmall molecule
Therapeutic areaDermatology
PhasePhase 3

Mechanism of action

Adapalene binds to retinoic acid receptors (RARs) in skin cells, promoting cell turnover and reducing comedone formation. It decreases sebum production and has anti-inflammatory properties, making it effective for treating acne by preventing the formation of microcomedones and reducing bacterial colonization.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results